COVID-19 vaccine maker Moderna (Nasdaq:MRNA) has announced that its chief financial officer (CFO) Jorge Gomez has resigned in his first week.
Gomez’s former employer Dentsply Sirona (Nasdaq: XRAY), announced an “ongoing internal investigation into certain matters, including financial reporting,” according to a Moderna news release.
Gomez will receive 12 months’ salary, amounting to $700,000. He will also give up his $500,000 signing bonus and bonus eligibility.
Cambridge, Massachusetts–based Moderna had announced its appointment of Gomez in April. He assumed the role on May 9.
Moderna’s former CFO, David Meline, will return to the role until the company finds a replacement.
Jorge Gomez
In April, the dental products company Dentsply Sirona fired its CEO, Don Casey, and removed him from its board. Case had assumed the CEO role in February 2018.
Dentsply Sirona recently disclosed that it was investigating whether “former and current members of senior management” were involved in financial reporting fraud.
In particular, the company is seeking additional information on the use of incentives to market products to distributors and their role in achieving executive compensation targets in 2021.
Dentsply Sirona’s audit committee has obtained independent outside counsel, which, in turn, has enlisted a forensic accounting company to assist in the investigation, according to an SEC filing.
In December 2020, SEC settled charges against Dentsply Sirona for “failing to make certain required disclosures in periodic reports filed with the SEC.”
MRNA shares fell 2.51% to $129.00 in mid-day trading while Dentsply Sirona’s increased about 5% to $38.24.